Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP2A | P11388 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | CTSK | P43235 | 1/20 | 0.45 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22056886 | 1.00 | TOP2A (0.51) | TOP2ALMNACTSKSLC2A1KDM4E | |
| SCHEMBL5701327 | 0.88 | LMNA (0.49) | TOP2ALMNACTSKKDM4EUSP2 | |
| SCHEMBL10755244 | 0.85 | LMNA (0.47) | TOP2ALMNASLC2A1KDM4EUSP2 | |
| SCHEMBL10697881 | 0.82 | TOP2A (0.49) | TOP2ALMNASLC2A1KDM4EUSP2 | |
| SCHEMBL9319994 | 0.81 | TOP2A (0.70) | TOP2ALMNACTSKSLC2A1KDM4E | |
| SCHEMBL941093 | 0.81 | TOP2A (0.70) | TOP2ALMNACTSKSLC2A1KDM4E | |
| SCHEMBL941092 | 0.81 | TOP2A (0.70) | TOP2ALMNACTSKSLC2A1KDM4E | |
| SCHEMBL800985 | 0.81 | AGTR1 (0.53) | TOP2ALMNAKDM4ENPC1RAB9A | |
| SCHEMBL3087162 | 0.81 | TOP2A (0.49) | TOP2ALMNASLC2A1KDM4EHTT | |
| SCHEMBL29402921 | 0.81 | AGTR1 (0.53) | TOP2ALMNAKDM4ENPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101787000-B | M-stage kinesin inhibitor | KYOWA HAKKO KOGYO KK | 2011-08-03 | — | — | CN | disclosed |
| CN-101787000-A | M-stage kinesin inhibitor | KYOWA HAKKO KOGYO KK | 2010-07-28 | — | — | CN | disclosed |
| CN-1774428-B | M-phase kinesin inhibitors | KYOWA HAKKO KOGYO KK | 2010-06-16 | — | — | CN | disclosed |
| CN-100484928-C | thiadiazoline derivatives | KYOWA HAKKO KOGYO KK FUJI PHOT (JP) | 2009-05-06 | — | — | CN | disclosed |
| EP-1377591-B1 | TUMOUR INHIBITING GALLIUM COMPOUNDS | FAUSTUS FORSCHUNGS CIE (DE) | 2006-06-28 | — | — | EP | disclosed |
| CN-1774428-A | M-phase kinesin inhibitors | KYOWA HAKKO KOGYO KK (JP) | 2006-05-17 | — | — | CN | disclosed |
| CN-1617864-A | thiadiazoline derivatives | KYOWA HAKKO KOGYO KK (JP) | 2005-05-18 | — | — | CN | disclosed |
| EP-0831806-A1 | MULTIDENTATE METAL COMPLEXES AND METHODS OF MAKING AND USING THEREOF | WASHINGTON UNIVERSITY (US) | 1998-04-01 | — | — | EP | disclosed |
| WO-1996040108-A1 | MULTIDENTATE METAL COMPLEXES AND METHODS OF MAKING AND USING THEREOF | WASHINGTON UNIVERSITY (US) | 1996-12-19 | — | — | WO | disclosed |
| US-5270037-A | Use of interferon and a substance with an antimalarial activity for the treatment of malaria infections | BOEHRINGER INGELHEIM GMBH (DE) | 1993-12-14 | — | — | US | disclosed |
| US-4739069-A | TREATMENT OF GONORRHEA, MALARIA, INFECTIONS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1988-04-19 | — | — | US | disclosed |
| EP-0243101-A2 | Insecticidal 6-aryl-pyridine thiosemicarbazones | ROHM AND HAAS COMPANY (US) | 1987-10-28 | — | — | EP | disclosed |
| US-4696938-A | Insecticidal 6-aryl-pyridine thiosemicarbazones | ROHM AND HAAS COMPANY (US) | 1987-09-29 | — | — | US | disclosed |
| US-4657903-A | Transition metal complexes of the selenium analogs of 2-acetyl- and 2-propionylpyridine thiosemicarbazones useful for treating malarial infections and leukemia | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1987-04-14 | — | — | US | disclosed |
| US-4657903-A | Transition metal complexes of the selenium analogs of 2-acetyl- and 2-propionylpyridine thiosemicarbazones useful for treating malarial infections and leukemia | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1987-04-14 | — | — | US | disclosed |
| US-4493930-A | BACTERICIDES, ANTIMALARIA, AND ANTIGONORRHEA AGENTS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1985-01-15 | — | — | US | disclosed |
| US-4493930-A | BACTERICIDES, ANTIMALARIA, AND ANTIGONORRHEA AGENTS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1985-01-15 | — | — | US | disclosed |
| US-4447427-A | PARTICULARLY GONORRHEA OR MALARIA | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1984-05-08 | — | — | US | disclosed |
| US-4447427-A | PARTICULARLY GONORRHEA OR MALARIA | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1984-05-08 | — | — | US | disclosed |
| US-4401670-A | Method for treating gonorrhea infections with 2-acetyl- and 2-propionylpyridine thiosemicarbazones | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1983-08-30 | — | — | US | disclosed |